- Licensed for use with USG projects
- Platform can be used for a variety of target antigens
- Libraries of yeast and phage displayed Complementarity-determining
regions - Design and selection of V regions improves manufacturability
- Production platform format improves product attributes
- Design supports similar pharmacokinetics for co-mixtures
- Reduces potential for drug product antigenicity
- Enables standard, systematic formulation approach with reduced aggregation and degradation
- Platform provides for optimization of a variety of antibody characteristics and humanization
Advanced Development And Manufacturing of Antibody Technologies (ADAMANT)Ray Peck2018-02-08T15:33:37-05:00